Want to see PROK full AI Analyst Report?
ProKidney (PROK) Ratios
374 Followers
ProKidney Ratios
PROK's free cash flow for Q2 2026 was $-44.21M. For the 2026 fiscal year, PROK's free cash flow was decreased by $-3.83M and operating cash flow was $-40.37M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Mar 25 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 9.13 | 10.93 | 14.94 | 46.42 | 2.21 |
| Quick Ratio | 9.13 | 10.93 | 14.94 | 46.42 | 2.21 |
| Cash Ratio | 3.53 | 2.74 | 2.42 | 45.09 | 1.67 |
| Solvency Ratio | -1.79 | -1.41 | -1.08 | -8.04 | -3.97 |
| Operating Cash Flow Ratio | -3.91 | -3.49 | -3.60 | -7.09 | -4.08 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 245.90M | $ 356.45M | $ 344.93M | $ 491.66M | $ 13.89M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.01 | 0.01 | 0.01 | 0.00 | 0.03 |
| Debt-to-Equity Ratio | -0.00 | -0.00 | -0.00 | -0.00 | 0.05 |
| Debt-to-Capital Ratio | -0.00 | -0.00 | -0.00 | -0.00 | 0.05 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | -0.33 | -0.44 | -0.38 | -0.47 | 1.50 |
| Debt Service Coverage Ratio | -36258.25 | -17543.78 | -10965.17 | -673.88 | 0.00 |
| Interest Coverage Ratio | -41251.75 | -20408.44 | -12626.83 | -711.66 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.03 | 0.03 | 0.07 | 0.04 | 0.04 |
| Net Debt to EBITDA | 0.72 | 0.60 | 0.45 | 3.39 | 0.36 |
| Profitability Margins | |||||
| Gross Profit Margin | 100.00% | 100.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | -16931.02% | -215689.47% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | -16194.74% | -208542.11% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | -18477.83% | -241678.95% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | -16931.47% | -215701.32% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | -7725.20% | -80507.89% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | -16977.83% | -214914.47% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 45.63% | 37.32% | 27.40% | 73.37% | 100.07% |
| EBT Per EBIT | 91.63% | 89.25% | 85.43% | 96.23% | 100.00% |
| Return on Assets (ROA) | -20.56% | -13.87% | -8.43% | -20.86% | -136.85% |
| Return on Equity (ROE) | 6.82% | 6.15% | 3.21% | 9.85% | -204.87% |
| Return on Capital Employed (ROCE) | -54.13% | -45.37% | -38.31% | -30.17% | -196.93% |
| Return on Invested Capital (ROIC) | -53.94% | -45.12% | -38.23% | -30.14% | -195.07% |
| Return on Tangible Assets | -20.56% | -13.87% | -8.43% | -20.86% | -138.31% |
| Earnings Yield | -22.99% | -36.98% | -32.29% | -25.59% | -17.47% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.79 | 0.03 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 460.64 | 11752.04 | 0.00 | 0.00 | 0.00 |
| Days of Sales Outstanding | 460.64 | 11752.04 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 460.64 | 11752.04 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.90 | -1.29 | -1.46 | -1.25 | -1.58 |
| Free Cash Flow Per Share | -1.01 | -1.59 | -2.01 | -1.28 | -1.74 |
| Dividend Paid and CapEx Coverage Ratio | -7.90 | -4.28 | -2.63 | -41.76 | -9.69 |
| Capital Expenditure Coverage Ratio | -7.90 | -4.28 | -2.63 | -41.76 | -9.69 |
| Operating Cash Flow Coverage Ratio | -29.76 | -39.05 | -20.41 | -32.13 | -37.71 |
| Operating Cash Flow to Sales Ratio | -134.51 | -1662.51 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -45.10% | -94.19% | -113.12% | -18.70% | -17.58% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -4.31 | -2.73 | -3.10 | -3.91 | -5.73 |
| Price-to-Sales (P/S) Ratio | 335.98 | 2177.35 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | -0.30 | -0.17 | -0.10 | -0.38 | 11.73 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -2.22 | -1.06 | -0.88 | -5.35 | -5.69 |
| Price-to-Operating Cash Flow Ratio | -2.50 | -1.31 | -1.22 | -5.48 | -6.28 |
| Price-to-Earnings Growth (PEG) Ratio | 0.27 | -0.31 | 0.05 | -2.25 | -0.01 |
| Enterprise Value Multiple | -3.99 | -1.76 | -1.54 | -3.27 | -13.13 |
| Enterprise Value | 576.40M | 279.66M | 193.06M | 470.22M | 697.26M |
| EV to EBITDA | -3.99 | -1.76 | -1.54 | -3.27 | -13.13 |
| EV to Sales | 645.46 | 3679.70 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -4.26 | -1.79 | -1.55 | -5.96 | -12.57 |
| EV to Operating Cash Flow | -4.80 | -2.21 | -2.14 | -6.10 | -13.86 |
| Tangible Book Value Per Share | 2.25 | 4.10 | 6.34 | 8.20 | 0.83 |
| Shareholders’ Equity Per Share | -7.55 | -10.16 | -17.88 | -17.82 | 0.84 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | 0.00 | -0.05 | -0.01 | -0.00 |
| Revenue Per Share | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.52 | -0.62 | -0.57 | -1.76 | -1.73 |
| Tax Burden | 0.46 | 0.37 | 0.27 | 0.73 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 127.80 | 1679.84 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 57.98 | 737.95 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 28.37 | 386.47 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.79 | 0.77 | 0.66 | 0.52 | 0.91 |
Currency in USD
